Glenmede Trust CO Na Galapagos Nv Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $6,295 - $9,636	-65 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$122.47 - $213.56 $244 - $427	-2 Reduced 2.99%	65 $9,000
Q2 2020 Aug 14, 2020	BUY	$185.52 - $231.25 $10,945 - $13,643	59 Added 737.5%	67 $13,000
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $913 - $1,313	-7 Reduced 46.67%	8 $1,000
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $1,317 - $1,659	15 New	15 $1,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.